SLC30A7 and myeloid sarcoma: The rule with the highest confidence (0.95) was {HLA-DRB1*15:01, SLC30A7-rs56678847, AC093277.1-rs6880809} →{MS}; this risk variant pattern existed in 21 of 386 study participants, of whom 95% were MS cases (n = 20) and only one was a control.